Heart failure & cardiomyopathies

Predictive Modeling to Assess Pretest Probability of Transthyretin Gene Variants Based on Demographic Information

Circ Heart FailPublished Cohort study

Authors' conclusion

This CART algorithm incorporating age, sex, and race was able to determine which patients with ATTR-CM have pathogenic TTR mutations with high specificity. Non-Black patients diagnosed at age 69 years or older with ATTR-CM have a low likelihood to have ATTRv.

Study context

Population
Consecutive patients diagnosed with transthyretin amyloid cardiomyopathy (ATTR-CM) who underwent genetic testing
Participants
767 patients
Outcome
Decision tree's accuracy in 2 separate institutions' ATTR-CM registry
Methodological details2 institutions' ATTR-CM registries, validation cohort
  • 2 institutions' ATTR-CM registries
  • Validation cohort

Main finding

As reported in the abstract

Prediction of pathologic TTR variant (validation cohort)
GroupAccuracySensitivitySpecificity
Classification and regression trees (CART) algorithm88.2%75.3%93.9%

Classification and regression trees (CART) algorithm

Accuracy88.2%
Sensitivity75.3%
Specificity93.9%

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)P value
TTR gene variant, Blackvs non-Black patients (logistic regression)34.6 (20.5–58.3)P < 0.001

Prevalence of ATTRv in study cohort

Patients with ATTRv
208 (27.1%)

Risk of predisposing mutation in non-Black patients aged ≥69 years

Risk of predisposing mutation
<4%

Original publication

Predictive Modeling to Assess Pretest Probability of Transthyretin Gene Variants Based on Demographic Information. Circ Heart Fail. Published 20 January 2023. doi:10.1161/circheartfailure.122.009908

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.